한글목차

혈전 제거 기기 시장은 2025년에 19억 5,000만 달러, 2032년에는 32억 4,000만 달러에 이를 것으로 예측되며, 2025-2032년 연평균 복합 성장률(CAGR) 7.5%로 성장할 전망입니다.

혈전제거술은 외과 의사가 관상동맥 내 카테터와 같은 기계적 혈전 제거 장치를 사용하여 혈전을 파괴하거나 제거하여 인체의 정상적인 혈류를 회복시키는 것입니다. 특히 대동맥 뇌졸중을 경험한 환자의 건강을 개선하기 위해 신경외과 의사에게 도움이 되고 있습니다. 혈전제거술은 중국, 인도, 호주 등 아시아태평양의 주요 경제권에서 널리 사용되고 있습니다. 혈전 제거 장치는 최근 수술을 받았거나 경구용 항응고제를 복용하는 환자 등 혈전 용해 요법과 같은 약리학적 치료가 효과가 없거나 부적절할 가능성이 높은 환자에게 사용할 수 있습니다.

시장 역학

혈전제거기는 동맥, 정맥, 모세혈관에 존재하는 혈전을 치료하는 데 사용됩니다. 혈전 제거 장치는 혈전 제거 시술 중 혈관벽 손상을 최소화하고 출혈을 최소화하도록 세심하게 설계되어 있습니다. 저침습적 혈전 제거술에 대한 수요 증가는 세계 혈전 제거 장치 시장의 성장을 가속할 것으로 예측됩니다. 예를 들어, 2020년 미국심장협회(AHA) 저널에 따르면, 코로나19 환자는 16.7%의 환자가 부정맥, 23%의 환자가 심부전 등 많은 심혈관계 합병증을 앓고 있어 급성 허혈성 뇌졸중 위험이 증가합니다. 뇌혈관 합병증은 전 세계적으로 중증 코로나19 환자의 5-6%에서 보고되고 있습니다. 이에 따라 뇌졸중에 대한 혈관 내 치료(EVT)에 대한 접근성을 개선하고, 시간을 단축하고, 뇌졸중 후 예후를 개선하는 것에 대한 관심이 높아지고 있습니다.

본 보고서의 주요 특징

• 세계의 혈전 제거 장치 시장에 대해 조사 분석했으며, 2024년을 기준 연도로 하여 예측 기간(2025-2032년) 시장 규모와 연평균 성장률(CAGR)에 대해 조사 분석하여 전해드립니다.
• 또한, 각 부문의 잠재적 수익 기회를 밝히고, 이 시장의 매력적인 투자 제안 매트릭스를 설명합니다.
• 또한, 시장 촉진 및 억제요인 및 기회, 신제품 출시 및 승인, 시장 동향, 지역별 전망, 주요 업체들의 경쟁 전략 등에 대한 중요한 고찰을 제공합니다.
• 이 보고서는 기업 개요, 제품 포트폴리오, 주요 특징, 재무 성과, 전략 등의 매개 변수를 기반으로 세계 혈전 제거 장치 시장의 주요 기업 프로파일을 제공합니다.
• 이 보고서의 통찰력을 통해 마케팅 담당자와 기업 경영진은 향후 제품 출시, 제휴, 시장 확대, 마케팅 전략에 대한 정보에 입각한 의사결정을 내릴 수 있습니다.
• '세계 혈전 제거 장치 시장' 보고서는 투자자, 공급업체, 제품 제조업체, 유통업체, 신규 시장 진출기업, 재무 분석가 등 다양한 이해관계자를 대상으로 합니다.
• 이해관계자들은 세계 혈전 제거 장치 시장 분석에 사용되는 다양한 전략 매트릭스를 통해 의사결정을 용이하게 할 수 있습니다.

목차

제1장 분석 목적과 전제조건

• 분석 목적
• 전제조건
• 약어

제2장 시장 전망

• 보고서 설명
  • 시장 정의와 범위
• 주요 요약
• Coherent Opportunity Map(COM)

제3장 시장 역학, 규제 및 동향 분석

• 시장 역학
  • 성장 촉진요인
  • 성장 억제요인
  • 시장 기회
• 영향 분석
• 최근 제품 승인/발매
• 인수합병(M&A), 제휴
• 규제 시나리오
• 가격 분석
• 주요 발전
• PEST 분석
• Porter의 Five Forces 분석

제4장 세계의 혈전 제거 기기 시장 : 제품 유형별(2020-2032년)

• 기계식 혈전 제거 기기
• 흡인식 혈전 제거 기기
• 유체 역학식 혈전 제거 기기
• 초음파식 혈전 제거 기기

제5장 세계의 혈전 제거 기기 시장 : 용도별(2020-2032년)

• 심부정맥 혈전증(DVT)
• 폐색전증(PE)
• 표재 정맥혈전 증
• 신장 정맥혈전 증(RVT)
• 동맥혈전증(어테로머 혈전증)
• 기타(허혈성 뇌졸중 등)

제6장 세계의 혈전 제거 기기 시장 : 최종사용자별(2020-2032년)

• 병원
• 외래수술센터(ASC)
• 기타(학술연구기관 등)

제7장 세계의 혈전 제거 기기 시장 : 지역별(2020-2032년)

• 북미
  • 미국
  • 캐나다
• 유럽
  • 영국
  • 독일
  • 이탈리아
  • 프랑스
  • 스페인
  • 러시아
  • 기타 유럽
• 아시아태평양
  • 중국
  • 인도
  • 일본
  • ASEAN
  • 호주
  • 한국
  • 기타 아시아태평양
• 라틴아메리카
  • 브라질
  • 멕시코
  • 아르헨티나
  • 기타 라틴아메리카
• 중동
  • GCC
  • 이스라엘
  • 기타 중동
• 아프리카
  • 북아프리카
  • 중앙아프리카
  • 남아프리카공화국

제8장 경쟁 구도

• 기업 개요
  • Boston Scientific Corporation
  • Medtronic
  • Merit Medical System Inc.
  • Stryker Corporation
  • Terumo Corporation
  • Teleflex Incorporated
  • Vetex Medical Ltd.
  • Edwards Lifesciences Corporation
  • Penumbra Inc.
  • Control Medical Technology, LLC.
  • Rapid Medical
  • Abbott
  • Surmodics Inc.
  • Analysts'Views

제9장 섹션

• 참고 문헌
• 분석 방법

영문목차

Thrombectomy Devices Market is estimated to be valued at USD 1.95 Bn in 2025 and is expected to reach USD 3.24 Bn by 2032, growing at a compound annual growth rate (CAGR) of 7.5% from 2025 to 2032.

Thrombectomy procedures allow surgeons to use a mechanical thrombectomy device such as intracoronary catheters to break up or remove the blood clot and restore normal blood flow in the human body. It helps neurosurgeons to improve patients' health, especially those experiencing a large artery stroke. Thrombectomy is widely used in major economies of Asia Pacific such as China, India, Australia, and others, due to high number of stroke incidences and increased spending in healthcare. Thrombectomy devices can be used in patients for whom pharmacological treatments such as thrombolysis are likely to be ineffective or inappropriate, for instance, in case of recent surgery or in patients who are taking oral anticoagulants.

Market Dynamics

Thrombectomy devices are used to treat blood clots present in the arteries, veins, and capillaries. Thrombectomy devices are carefully designed to minimize damage to the vessel wall during a blood clot removal procedure, with minimum blood loss. The rising demand for minimally invasive thrombectomy procedures is expected to drive the growth of the global thrombectomy devices market. For instance, as per a publication by the American Heart Association (AHA) Journals in 2020, patients with COVID-19 suffer from a number of cardiovascular complications, including 16.7% patients suffer from arrhythmia and 23% of patients suffer from heart failure, thus increasing risk for acute ischemic stroke. Cerebrovascular complications have been reported in 5% to 6% of patients with severe COVID-19, globally. This has increased concerns to improve the accessibility and shorten the time to endovascular therapy (EVT) for stroke to give patients better outcome after strokes.

Key features of the study

• This report provides in-depth analysis of the global thrombectomy devices market, and provides market size (USD Bn) and compound annual growth rate (CAGR%) for the forecast period 2025-2032, considering 2024 as the base year.
• It elucidates potential revenue opportunities across different segments and explains attractive investment proposition matrices for this market.
• This study also provides key insights about market drivers, restraints, opportunities, new product launches or approval, market trends, regional outlook, and competitive strategies adopted by key players.
• It profiles key players in the global thrombectomy devices market based on the following parameters - company highlights, products portfolio, key highlights, financial performance, and strategies.
• Key companies covered as a part of this study include LeMaitre Vascular, Inc., Boston Scientific Corporation, Control Medical Technology, Edwards Lifesciences Corporation, Johnson & Johnson, Medtronic Plc., Merit Medical Systems, Inc., Stryker Corporation, Terumo Corporation, Penumbra, Inc., Argon Medical Devices, Teleflex Incorporated, and Vetex Medical Ltd.
• Insights from this report would allow marketers and the management authorities of the companies to make informed decisions regarding their future product launches, type up-gradation, market expansion, and marketing tactics.
• The global thrombectomy devices market report caters to various stakeholders in this industry including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts.
• Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the global thrombectomy devices market.

Market Segmentation

• By Product Type
  • Mechanical Thrombectomy Devices
  • Aspiration Thrombectomy Devices
  • Hydrodynamic Thrombectomy Devices
  • Ultrasonic Thrombectomy Devices
• By Application
  • Deep Vein Thrombosis (DVT)
  • Pulmonary Embolism (PE)
  • Superficial Vein Thrombosis
  • Renal Vein Thrombosis (RVT)
  • Arterial Thrombosis (Atherothrombosis)
  • Others (Ischemic Stroke, etc.)
• By End User
  • Hospitals
  • Ambulatory Surgical Centers
  • Others (Academic and Research Institutes, etc)
• By Region
  • North America
  • U.S.
  • Canada
  • Latin America
  • Brazil
  • Argentina
  • Mexico
  • Rest of Latin America
  • Europe
  • Germany
  • U.K.
  • Spain
  • France
  • Italy
  • Russia
  • Rest of Europe
  • Asia Pacific
  • China
  • India
  • Japan
  • Australia
  • South Korea
  • ASEAN
  • Rest of Asia Pacific
  • Middle East
  • GCC Countries
  • Israel
  • Rest of Middle East
  • Africa
  • South Africa
  • North Africa
  • Central Africa
• Key Players
  • Boston Scientific Corporation
  • Medtronic
  • Merit Medical System Inc.
  • Stryker Corporation
  • Terumo Corporation
  • Teleflex Incorporated
  • Vetex Medical Ltd.
  • Edwards Lifesciences Corporation
  • Penumbra Inc.
  • Control Medical Technology LLC.
  • Rapid Medical
  • Abbott
  • Surmodics, Inc.

Table of Contents

1. Research Objective and Assumption

• Research Objectives
• Assumptions
• Abbreviations

2. Market Purview

• Report Description
  • Market Definition and Scope
• Executive Summary
  • Market Snippet, By Product Type
  • Market Snippet, By Application
  • Market Snippet, By End User
  • Market Snippet, By Region
• Coherent Opportunity Map (COM)

3. Market Dynamics, Regulations, and Trends Analysis

• Market Dynamics
  • Drivers
  • Restraints
  • Market Opportunities
• Impact Analysis
• Recent Product Approvals/Launches
• Mergers, Acquisitions, and Collaborations
• Regulatory Scenario
• Pricing Analysis
• Key Developments
• PEST Analysis
• Porter's Analysis

4. Global Thrombectomy Devices Market, By Product Type, 2020- 2032, (USD Bn)

• Introduction
  • Market Share Analysis, 2025 and 2032 (%)
  • Y-o-Y Growth Analysis, 2021-2032
  • Segment Trends
• Mechanical Thrombectomy Devices
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2020 - 2032, (USD Bn)
  • Segment Trends
• Aspiration Thrombectomy Devices
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2020 - 2032, (USD Bn)
  • Segment Trends
• Hydrodynamic Thrombectomy Devices
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2020 - 2032, (USD Bn)
  • Segment Trends
• Ultrasonic Thrombectomy Devices
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2020 - 2032, (USD Bn)
  • Segment Trends

5. Global Thrombectomy Devices Market, By Application, 2020 - 2032, (USD Bn)

• Introduction
  • Market Share Analysis, 2025 and 2032 (%)
  • Y-o-Y Growth Analysis, 2021-2032
  • Segment Trends
• Deep Vein Thrombosis (DVT)
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2020 - 2032, (USD Bn)
  • Segment Trends
• Pulmonary Embolism (PE)
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2020 - 2032, (USD Bn)
  • Segment Trends
• Superficial Vein Thrombosis
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2020 - 2032, (USD Bn)
  • Segment Trends
• Renal Vein Thrombosis (RVT)
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2020 - 2032, (USD Bn)
  • Segment Trends
• Arterial Thrombosis (Atherothrombosis)
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2020 - 2032, (USD Bn)
  • Segment Trends
• Others (Ischemic Stroke, etc.)
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2020 - 2032, (USD Bn)
  • Segment Trends

6. Global Thrombectomy Devices Market, By End User, 2020 - 2032, (USD Bn)

• Introduction
  • Market Share Analysis, 2025 and 2032 (%)
  • Y-o-Y Growth Analysis, 2021-2032
  • Segment Trends
• Hospitals
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2020 - 2032, (USD Bn)
• Ambulatory Surgical Centers
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2020 - 2032, (USD Bn)
• Others (Academic and Research Institutes, etc.)
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2020 - 2032, (USD Bn)

7. Global Thrombectomy Devices Market, By Region, 2020 - 2032, (USD Bn)

• Introduction
  • Market Share Analysis, 2025 and 2032 (%)
  • Y-o-Y Growth Analysis, 2021-2032
  • Segment Trends
• North America
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, By Product Type, 2020 -2032, (USD Bn)
  • Market Size and Forecast, and Y-o-Y Growth, By Application, 2020 -2032, (USD Bn)
  • Market Size and Forecast, and Y-o-Y Growth, By End User, 2020-2032, (USD Bn)
  • Market Size and Forecast, and Y-o-Y Growth, By Country, 2020 -2032, (USD Bn)
    • U.S.
    • Canada
• Europe
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, By Product Type, 2020 -2032, (USD Bn)
  • Market Size and Forecast, and Y-o-Y Growth, By Application, 2020 -2032, (USD Bn)
  • Market Size and Forecast, and Y-o-Y Growth, By End User, 2020-2032, (USD Bn)
  • Market Size and Forecast, and Y-o-Y Growth, By Country, 2020 -2032, (USD Bn)
    • U.K.
    • Germany
    • Italy
    • France
    • Spain
    • Russia
    • Rest of Europe
• Asia Pacific
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth. By Product Type, 2020 -2032, (USD Bn)
  • Market Size and Forecast, and Y-o-Y Growth, By Application, 2020 -2032, (USD Bn)
  • Market Size and Forecast, and Y-o-Y Growth, By End User, 2020-2032, (USD Bn)
  • Market Size and Forecast, and Y-o-Y Growth, By Country, 2020 -2032, (USD Bn)
    • China
    • India
    • Japan
    • ASEAN
    • Australia
    • South Korea
    • Rest of Asia Pacific
• Latin America
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, By Product Type, 2020 -2032, (USD Bn)
  • Market Size and Forecast, and Y-o-Y Growth, By Application, 2020 -2032, (USD Bn)
  • Market Size and Forecast, and Y-o-Y Growth. By End User, 2020-2032, (USD Bn)
  • Market Size and Forecast, and Y-o-Y Growth, By Country, 2020 -2032, (USD Bn)
    • Brazil
    • Mexico
    • Argentina
    • Rest of Latin America
• Middle East
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth By Product Type, 2020 -2032, (USD Bn)
  • Market Size and Forecast, and Y-o-Y Growth By Application, 2020 -2032, (USD Bn)
  • Market Size and Forecast, and Y-o-Y Growth By End User, 2020-2032, (USD Bn)
  • Market Size and Forecast, and Y-o-Y Growth By Country, 2020 -2032, (USD Bn)
    • GCC
    • Israel
    • Rest of Middle East
• Africa
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, By Product Type, 2020 -2032, (USD Bn)
  • Market Size and Forecast, and Y-o-Y Growth, By Application, 2020 -2032, (USD Bn)
  • Market Size and Forecast, and Y-o-Y Growth, By End User, 2020-2032, (USD Bn)
  • Market Size and Forecast, and Y-o-Y Growth, By Country/Region, 2020 -2032, (USD Bn)
    • North Africa
    • Central Africa
    • South Africa

8. Competitive Landscape

• Company Profiles
  • Boston Scientific Corporation
    • Company Overview
    • Product Portfolio
    • Key Highlights
    • Financial Overview
    • Strategies
  • Medtronic
    • Company Overview
    • Product Portfolio
    • Key Highlights
    • Financial Overview
    • Strategies
  • Merit Medical System Inc.
    • Company Overview
    • Product Portfolio
    • Key Highlights
    • Financial Overview
    • Strategies
  • Stryker Corporation
    • Company Overview
    • Product Portfolio
    • Key Highlights
    • Financial Overview
    • Strategies
  • Terumo Corporation
    • Company Overview
    • Product Portfolio
    • Key Highlights
    • Financial Overview
    • Strategies
  • Teleflex Incorporated
    • Company Overview
    • Product Portfolio
    • Key Highlights
    • Financial Overview
    • Strategies
  • Vetex Medical Ltd.
    • Company Overview
    • Product Portfolio
    • Key Highlights
    • Financial Overview
    • Strategies
  • Edwards Lifesciences Corporation
    • Company Overview
    • Product Portfolio
    • Key Highlights
    • Financial Overview
    • Strategies
  • Penumbra Inc.
    • Company Overview
    • Product Portfolio
    • Key Highlights
    • Financial Overview
    • Strategies
  • Control Medical Technology, LLC.
    • Company Overview
    • Product Portfolio
    • Key Highlights
    • Financial Overview
    • Strategies
  • Rapid Medical
    • Company Overview
    • Product Portfolio
    • Key Highlights
    • Financial Overview
    • Strategies
  • Abbott
    • Company Overview
    • Product Portfolio
    • Key Highlights
    • Financial Overview
    • Strategies
  • Surmodics Inc.
    • Company Overview
    • Product Portfolio
    • Key Highlights
    • Financial Overview
    • Strategies
  • Analysts' Views

9. Section

• References
• Research Methodology
• About us and Sales Contact